Metraipolis › archive › dc_ccb85e4fffab
Nanomaterial-based strategies to overcome sorafenib resistance in hepatocellular carcinoma: from mechanistic insights to translational applications — Europe PMC PMID:42245685
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42245685
- DOI
- 10.3389/fonc.2026.1839966
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-01T10:28:55.568Z
- SHA-256 of the archived text
8c50bd7d9a0193848fc5332476297a18494f85959b8415299473ce43f9618661- Stable URL of this page
https://metraipolis.com/documento/dc_ccb85e4fffab
How to cite
Nanomaterial-based strategies to overcome sorafenib resistance in hepatocellular carcinoma: from mechanistic insights to translational applications — Europe PMC PMID:42245685 — Europe PMC (en), https://europepmc.org/article/MED/42245685 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ccb85e4fffab (Metraipolis archive dc_ccb85e4fffab, sha256 8c50bd7d9a0193848fc5332476297a18494f85959b8415299473ce43f9618661)
BibTeX
@misc{dcccb85e4fffab,
title = {Nanomaterial-based strategies to overcome sorafenib resistance in hepatocellular carcinoma: from mechanistic insights to translational applications — Europe PMC PMID:42245685},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42245685},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ccb85e4fffab; sha256 8c50bd7d9a0193848fc5332476297a18494f85959b8415299473ce43f9618661},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42245685. Agents can read the archived copy with the MCP tool read_document.